{"prompt": "['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', 'Visit 1, Study Day 1 - Screening, Enrollment, and Vaccination (Clinic Visit)', 'Obtain written informed consent and release of medical record information', 'Obtain information on preferred method of contact for follow-up (telephone, text or', 'email)', 'Review and confirm study eligibility and temporary delay criteria including pregnancy', 'status and pregnancy intention for women of childbearing potential.', 'For women of childbearing potential only, the study team can assess likelihood of', 'pregnancy based upon the following criteria if there are concerns regarding pregnancy.', 'If yes to any, can be reasonably certain not pregnant if no symptoms or signs of', 'pregnancy.', 'Is < 7 days after the start of menses', 'Has not had sexual intercourse since the start of last menses', 'Has been consistently using a reliable method of contraception', 'Is 7 days after spontaneous or induced abortion', 'Is within 4 weeks postpartum', 'Is fully or nearly fully breastfeeding (exclusively breastfeeding or the vast', 'majority 1 85%] of feeds are breastfeeds), amenorrheic and < 6 months', 'postpartum', 'Obtain demographic and medical history including history of influenza and COVID-19', 'vaccination and reported PCR test positive COVID-19 infection', 'Obtain concomitant medication use in preceding 30 days', 'Obtain baseline HRQOL assessment', 'Obtain oral temperature', 'Obtain 10mL blood sample prior to vaccination for serologic analysis (Section 5.6.1)', 'Randomize study participant to observer-blinded IIV4 or placebo (Section 5.2.1)', 'Participant will either receive or have just received (within 8 hours) mRNA COVID-19', 'vaccine per local standard of care or mRNA COVID-19 vaccine will be administered in', 'the deltoid muscle by trained, licensed research staff.', 'Trained, licensed unblinded staff will administer study product (IIV4 or placebo) in the', 'opposite deltoid muscle in which mRNA COVID-19 vaccine was administered', 'Ensure participants receive the IIV4 Vaccine Information Sheet (VIS) 30 and/or the', 'respective fact sheet for recipients and caregivers for mRNA COVID-19 vaccine during', 'visit13,32', 'Dispense paper memory aid (if subject selects paper), thermometer, and ruler (in order', 'to standardize measurements). Review instructions for use of thermometer, ruler, and', 'electronic memory aid completion.', 'Observe participant for a minimum of 30 minutes and assess for any immediate', 'reactogenicity symptoms', 'Confirm date of next appointment', 'Visit 1a, Study Days 1 - 7 Post Visit 1', 'Participants complete electronic or paper solicited symptom diary and HRQOL', 'assessment at approximately the same time each day for days 1-7', 'Participants using paper diary:', '31']['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', 'Study staff will call participants on day 3 post Visit 1 as a reminder to fill out the', 'symptom diary and HRQOL assessments on day 1-7 post Visit 1 regarding', 'reactogenicity events and to bring the diary card to the next visit.', 'Participants will be:', 'Asked to notify the study staff if they are hospitalized or have a severe', 'adverse event', 'Follow up with their healthcare provider if they have symptoms they find', 'concerning', 'Participants using REDCap web-based system:', 'Study staff will send daily reminders to fill out the symptom diary and HRQOL', 'Study staff will review REDCap system to confirm data capture and assess for', 'any AE or SAEs on day 3 and 8.', 'The study team will contact participants if they have any missing information. The', 'study team may also contact participants if more information is needed to better', 'describe AEs [including SAEs and severe (Grade 3) events] reported in the', 'REDCap web-based system.', 'All participants using the REDCAP web-based system will be:', 'Asked to notify the study staff if they are hospitalized or have a severe', 'adverse event', 'Follow up with their healthcare provider if they have symptoms they find', 'concerning', 'Visit 2, Study Day 15 Clinic Visit', 'Review any temporary delay criteria', 'Record any unsolicited AEs within the first 7 days post-vaccination, SAEs, AESI', 'Obtain concomitant medication use', 'Obtain oral temperature', 'Trained, licensed unblinded staff will administer IIV4 or placebo in the deltoid muscle', 'as described in Section 5.3.1.', 'Ensure participants receive the IIV4 Vaccine Information Sheet (VIS)', 'Ensure participants receive IIV4 Vaccine Verification', 'Dispense paper memory aid, thermometer if needed, and ruler if needed (in order to', 'standardize measurements). Review instructions for use of thermometer, ruler, and', 'electronic memory aid completion.', 'Observe participant for a minimum of 30 minutes and assess for any immediate', 'reactogenicity symptoms', 'Confirm date of next appointment', 'Visit 2a, Study Days 1 - 7 Post Visit 2', 'Participants complete electronic or paper solicited symptom diary each day at', 'approximately the same time each day for days 1-7', 'Participants using paper diary:', 'Study staff will call participants on day 3 post Visit 2 as a reminder to fill out the', 'symptom diary on day 1-7 post Visit 2 regarding reactogenicity events and to', 'bring the diary card to the next visit.', 'Participants will be:', '32']\n\n###\n\n", "completion": "END"}